Paper36770334
Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo.
Markelić M and 8 others. Nanomaterials (Basel), 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo. Papers, record 36770334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36770334
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 451-03-68/2022-14/200007 | Ministry of Education, Science and Technological Development of the Republic of Serbia | PubMed | ||
| 20/02847 | Zepter International | PubMed |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32036302 | Advances in nanomaterials for photodynamic therapy applications: Status and challenges. | Biomaterials | 2020 | https://conductscience.org/library/papers/32036302 | PubMed |
| 2 | 35262820 | Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8+ T-cell mediated cytotoxicity in colorectal cancer. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35262820 | PubMed |
| 3 | 33806466 | In Vivo Quantitative Vasculature Segmentation and Assessment for Photodynamic Therapy Process Monitoring Using Photoacoustic Microscopy. | Sensors (Basel) | 2021 | https://conductscience.org/library/papers/33806466 | PubMed |
| 4 | 16794636 | Photodynamic therapy and anti-tumour immunity. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16794636 | PubMed |
| 5 | 31472877 | Chitosan-coated liposomes to stabilize and enhance transdermal delivery of indocyanine green for photodynamic therapy of melanoma. | Carbohydr Polym | 2019 | https://conductscience.org/library/papers/31472877 | PubMed |
| 6 | 30832998 | Intralesional Cancer Immunotherapies. | Hematol Oncol Clin North Am | 2019 | https://conductscience.org/library/papers/30832998 | PubMed |
| 7 | 33262144 | Senescence and the SASP: many therapeutic avenues. | Genes Dev | 2020 | https://conductscience.org/library/papers/33262144 | PubMed |
| 8 | 32630174 | Reactive Oxygen Species and Antitumor Immunity-From Surveillance to Evasion. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32630174 | PubMed |
| 9 | 27364482 | A fate worse than death: apoptosis as an oncogenic process. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27364482 | PubMed |
| 10 | 33613512 | Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment. | Front Immunol | 2020 | https://conductscience.org/library/papers/33613512 | PubMed |
| 11 | 24278043 | Skin melanocytes: biology and development. | Postepy Dermatol Alergol | 2013 | https://conductscience.org/library/papers/24278043 | PubMed |
| 12 | 20078217 | The senescence-associated secretory phenotype: the dark side of tumor suppression. | Annu Rev Pathol | 2010 | https://conductscience.org/library/papers/20078217 | PubMed |
| 13 | 31675495 | Cellular Senescence: Defining a Path Forward. | Cell | 2019 | https://conductscience.org/library/papers/31675495 | PubMed |
| 14 | 17878918 | Melanosomes--dark organelles enlighten endosomal membrane transport. | Nat Rev Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17878918 | PubMed |
| 15 | 19704071 | Influence of melanosome dynamics on melanoma drug sensitivity. | J Natl Cancer Inst | 2009 | https://conductscience.org/library/papers/19704071 | PubMed |
| 16 | 31181772 | The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31181772 | PubMed |
| 17 | 31235879 | Unmasking senescence: context-dependent effects of SASP in cancer. | Nat Rev Cancer | 2019 | https://conductscience.org/library/papers/31235879 | PubMed |
| 18 | 30573629 | NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. | Science | 2018 | https://conductscience.org/library/papers/30573629 | PubMed |
| 19 | 29477613 | Hallmarks of Cellular Senescence. | Trends Cell Biol | 2018 | https://conductscience.org/library/papers/29477613 | PubMed |
| 20 | 27141342 | CD8 engineered cytotoxic T cells reprogram melanoma tumor environment. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27141342 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41623512 | Effects of Light-Induced Electromagnetic Fields on Human Cancer Cells in Vitro. | Bioelectricity | 2025 | https://conductscience.org/library/papers/41623512 | PubMed |
| 40731679 | Molecular "Yin-Yang" Machinery of Synthesis of the Second and Third Fullerene C60 Derivatives. | Micromachines (Basel) | 2025 | https://conductscience.org/library/papers/40731679 | PubMed |
| 39598477 | Effect of Particle Size on Physical Properties, Dissolution, In Vitro Antioxidant Activity, and In Vivo Hepatoprotective Properties of Tetrastigma hemsleyanum Diels et Gilg Powders. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39598477 | PubMed |
| 38470808 | Comparative Studies of the Structural and Physicochemical Properties of the First Fullerene Derivative FD-C60 (Fullerenol) and Second Fullerene Derivate SD-C60 (3HFWC). | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/38470808 | PubMed |
| 38138321 | The Second Derivative of Fullerene C60 (SD-C60) and Biomolecular Machinery of Hydrogen Bonds: Water-Based Nanomedicine. | Micromachines (Basel) | 2023 | https://conductscience.org/library/papers/38138321 | PubMed |
| 37049247 | Editorial for Special Issue "Cancer Treatment via Nanotherapy". | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/37049247 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD3E | 916 | PubTator's text mining | https://conductscience.org/library/genes/916 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD40 | 958 | PubTator's text mining | https://conductscience.org/library/genes/958 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| FOXP3 | 50943 | PubTator's text mining | https://conductscience.org/library/genes/50943 | NCBI Gene |
| IL2RA | 3559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
| ITGAM | 3684 | PubTator's text mining | https://conductscience.org/library/genes/3684 | NCBI Gene |
| MRC1 | 4360 | PubTator's text mining | https://conductscience.org/library/genes/4360 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36770334
GET https://conductscience.org/api/papers/v1/36770334/references?page=2